Recombinant multi-species PCGF1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PCGF1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
PCGF1 is a mammalian homolog of the Drosophila polycomb group genes, which act as transcriptional repressors to regulate anterior-posterior patterning in early embryonic development (Nunes et al., 2001 [PubMed 11287196]). See also PCGF2 (MIM 600346).[supplied by OMIM, Aug 2008]
The Alternative Names of target: 2010002K04Rik,NSPC1,Nervous system Polycomb-1 (NSPc1),Nspc1,PCGF1,Pcgf1,Polycomb group RING finger protein 1,RING finger protein 68,RNF3A-2,RNF68

Target products collectionGo to PCGF1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13020-Ag-1/ GM-Tg-hg-IP13020-Ag-2 Human PCGF1 protein Human
GM-Tg-rg-IP13020-Ag-1/ GM-Tg-rg-IP13020-Ag-2 Rat PCGF1 protein Rat
GM-Tg-mg-IP13020-Ag-1/ GM-Tg-mg-IP13020-Ag-2 Mouse PCGF1 protein Mouse
GM-Tg-cynog-IP13020-Ag-1/ GM-Tg-cynog-IP13020-Ag-2 Cynomolgus/Rhesus macaque PCGF1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13020-Ag-1/ GM-Tg-felg-IP13020-Ag-2 Feline PCGF1 protein Feline
GM-Tg-cang-IP13020-Ag-1/ GM-Tg-cang-IP13020-Ag-2 Canine PCGF1 protein Canine
GM-Tg-bovg-IP13020-Ag-1/ GM-Tg-bovg-IP13020-Ag-2 Bovine PCGF1 protein Bovine
GM-Tg-equg-IP13020-Ag-1/ GM-Tg-equg-IP13020-Ag-2 Equine PCGF1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13020-Ag-1/ GM-Tg-hg-IP13020-Ag-2; GM-Tg-rg-IP13020-Ag-1/ GM-Tg-rg-IP13020-Ag-2;
GM-Tg-mg-IP13020-Ag-1/ GM-Tg-mg-IP13020-Ag-2; GM-Tg-cynog-IP13020-Ag-1/ GM-Tg-cynog-IP13020-Ag-2;
GM-Tg-felg-IP13020-Ag-1/ GM-Tg-felg-IP13020-Ag-2; GM-Tg-cang-IP13020-Ag-1/ GM-Tg-cang-IP13020-Ag-2;
GM-Tg-bovg-IP13020-Ag-1/ GM-Tg-bovg-IP13020-Ag-2; GM-Tg-equg-IP13020-Ag-1/ GM-Tg-equg-IP13020-Ag-2
Products Name PCGF1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PCGF1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PCGF1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.